(Q73707460)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9301462%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Bone marrow protection with amifostine in the treatment of high-risk malignant lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9301462%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

A Avilés

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9301462%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J C Díaz-Maqueo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9301462%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A Talavera

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9301462%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

E L García

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9301462%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

R Guzmán

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9301462%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M J Nambo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9301462%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 July 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9301462%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9301462%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9301462%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9301462%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

1323-1325

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9301462%20AND%20SRC:MED&resulttype=core&format=json

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900127-5

7 January 2021

Intensive brief chemotherapy with hematopoietic growth factors as hematological support and adjuvant radiotherapy improve the prognosis in aggressive malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900127-5

7 January 2021

New protective agents for bone marrow in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900127-5

7 January 2021

Approaches to ablating the myelotoxicity of chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900127-5

7 January 2021

Amifostine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as a radioprotector and cytotoxic chemoprotector

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900127-5

7 January 2021

Protection of Normal Tissue from the Cytotoxic Effects of Chemotherapy and Radiation by Amifostine: Clinical Experiences

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900127-5

7 January 2021

Amifostine (WR-2721) Protects Normal Haematopoietic Stem Cells Against Cyclophosphamide Derivatives' Toxicity Without Compromising Their Antileukaemic Effects

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900127-5

7 January 2021

Amifostine, cisplatin, and vinblastine in metastatic non-small-cell lung cancer: a report of high response rates and prolonged survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900127-5

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900127-5

7 January 2021

10.1016/S0959-8049(97)00127-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9301462%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference